Evaluation of 177Lu-Labeled Pertuzumab F(ab ′)2 Fragments for HER2-Positive Cancer Targeting: A Comparative In Vitro and In Vivo Study

Cancer Biotherapy and Radiopharmaceuticals,Volume 39, Issue 1, Page 64-74, February 2024.

Source: Cancer Biotherapy and Radiopharmaceuticals - February 13, 2024 Category: Cancer & Oncology Authors: Rohit Sharma Archana Mukherjee Anuj Kumar Haladhar Dev Sarma Source Type: research